Track topics on Twitter Track topics that are important to you
Phone: (+41) 61-935 53 53
Fax: (+41) 61-935 53 00
Switzerland-based Carbogen Amcis, a pharmaceutical process development and active pharmaceutical ingredient manufacturing company, announced its Vionnaz site has successfully completed a Swissmedic in...
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as carbogen and niacinamide may make tumor cells more sensitive to radiation therapy. It is not yet k...
TITLE: A multicentre, randomised, phase III clinical trial comparing accelerated radiotherapy with accelerated radiotherapy plus carbogen and nicotinamide (ARCON) in clinical stage T2-4 ...
CarboGen and AMCIS, recognized as world leaders in the development chemistry market, combine world-class chemistry skills to provide seamless drug substance development and commercialization services....
CARBOGEN AMCIS, recognized as world leader in the development chemistry market, provides world-class chemistry skills to provide seamless drug substance development and commercialization services. D...
Faster-to-Market is the top priority of research-based pharmaceutical companies. CarboGen is a company that specializes in helping these companies accomplish this. For the last ten years CarboGen has ...
We have published hundreds of CARBOGEN AMCIS AG news stories on BioPortfolio along with dozens of CARBOGEN AMCIS AG Clinical Trials and PubMed Articles about CARBOGEN AMCIS AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CARBOGEN AMCIS AG Companies in our database. You can also find out about relevant CARBOGEN AMCIS AG Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...